More about
Serious And Life-Threatening Diseases
News
September 09, 2024
1 min read
Save
FDA grants rare pediatric disease designation to Descartes-08 for juvenile dermatomyositis
The FDA has granted rare pediatric disease designation to Descartes-08, an autologous mRNA cell therapy, for the treatment of juvenile dermatomyositis, Cartesian Therapeutics announced in a press release.